Literature DB >> 15131174

Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization.

Joao P Frade1, David W Warnock, Beth A Arthington-Skaggs.   

Abstract

We developed a rapid, sensitive, and reproducible assay to quantify Candida albicans ACT1, CDR1, CDR2, ERG11, and MDR1 mRNA using a two-step reverse transcription and LightCycler real-time PCR (RT-LightCycler PCR) method with sequence-specific hybridization probes. We compared RT-LightCycler PCR with Northern hybridization for quantitative analysis of gene expression in isolates with various fluconazole susceptibilities. Specificity of each LightCycler PCR was verified by LightCycler melting curve analysis and agarose gel electrophoresis of amplified products. Correlation of quantification results between RT-LightCycler PCR and Northern hybridization yielded correlation coefficients of > or = 0.91 for all genes except MDR1 (0.74). In this case, reduced correlation was due to the inability of Northern hybridization to accurately quantify the high MDR1 expression in a susceptible dose-dependent isolate which was shown by RT-LightCycler PCR to overexpress MDR1 >200-fold relative to the other isolates tested. In four isolates, low levels of CDR2 mRNA were detected by RT-LightCycler PCR but were undetectable by Northern hybridization. mRNA quantification by RT-LightCycler PCR correlates with Northern hybridization and offers additional advantages, including increased sensitivity and speed of analysis, along with lower RNA concentration requirements and an increased dynamic range of signal detection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131174      PMCID: PMC404661          DOI: 10.1128/JCM.42.5.2085-2093.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction.

Authors:  S Fronhoffs; G Totzke; S Stier; N Wernert; M Rothe; T Brüning; B Koch; A Sachinidis; H Vetter; Y Ko
Journal:  Mol Cell Probes       Date:  2002-04       Impact factor: 2.365

2.  Antifungal resistance in pathogenic fungi.

Authors:  Sofia Perea; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2002-11-01       Impact factor: 9.079

3.  Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors.

Authors:  K W Henry; J T Nickels; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 4.  Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

Authors:  Dominique Sanglard; Frank C Odds
Journal:  Lancet Infect Dis       Date:  2002-02       Impact factor: 25.071

5.  Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization.

Authors:  Rangaraj Selvarangan; Ajit P Limaye; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells.

Authors:  R D Smith; J Li; C T Noguchi; A N Schechter
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

7.  Reverse transcription - 3' rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 mRNA as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model.

Authors:  C N Okeke; R Tsuboi; M Kawai; M Yamazaki; S Reangchainam; H Ogawa
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

8.  Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species.

Authors:  J Loeffler; L Hagmeyer; H Hebart; N Henke; U Schumacher; H Einsele
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

9.  Quantification of Candida albicans actin mRNA by the LightCycler system as a means of assessing viability in a model of cutaneous candidiasis.

Authors:  C N Okeke; R Tsuboi; H Ogawa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

10.  Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.

Authors:  B A Arthington-Skaggs; D W Warnock; C J Morrison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

View more
  6 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

4.  Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR.

Authors:  Heleen Nailis; Tom Coenye; Filip Van Nieuwerburgh; Dieter Deforce; Hans J Nelis
Journal:  BMC Mol Biol       Date:  2006-08-04       Impact factor: 2.946

5.  Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.

Authors:  Sourour Neji; Ines Hadrich; Houaida Trabelsi; Salma Abbes; Fatma Cheikhrouhou; Hayet Sellami; Fattouma Makni; Ali Ayadi
Journal:  J Biomed Sci       Date:  2017-09-04       Impact factor: 8.410

Review 6.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.